Skip to main content
. 2019 Aug 23;20(10):e47911. doi: 10.15252/embr.201947911

Figure 6. Development of acute iron overload (IO) in vivo model and validation of IO and insulin resistance in skeletal muscle.

Figure 6

  • A
    Schematic diagram of iron‐dextran injections’ experimental plan.
  • B
    Prussian Perl blue staining in liver and skeletal muscle after iron injections.
  • C, D
    Representative Western blot images and quantification of ferritin and Tfr1 (indicated by arrowhead) to tubulin in skeletal muscles 24 h after iron injections. *< 0.05 (unpaired Student's t‐test versus control).
  • E
    Insulin tolerance test 24 h after iron injections.
  • F
    Glucose tolerance test (GTT) 24 h after iron injections.
  • G
    Quantification of area under curve in ITT (E). *< 0.05 (unpaired Student's t‐test versus control).
  • H
    Quantification of area under curve for panel (F). *< 0.05 (unpaired Student's t‐test versus control).
  • I, J
    Representative Western blot images and quantification of phospho‐IRS1 (Y612) and phospho‐AKT (T308) to GAPDH in skeletal muscles 24 h after iron injection followed by i.p. insulin injection. *< 0.05 (unpaired Student's t‐test versus control).
Data information: Results are presented as mean ± SEM. n = 6 males for ITT and GTT. n = 3 males for Western blot analysis. Scale bar = 50 μm.